Baird reiterated an Outperform rating and $7.00 price target on Curis (NASDAQ: CRIS) following the company's announcement that Aurigene has ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Pre-Open Stock Movers 09/07: (RTRX) (AAOI) (FRAN) (CMG) Higher; (SFM) (HDS) (CASY) Lower (more...)September 7, 2016 9:30 AM Curis (CRIS) Partner Aurigene Discovery Receives 10.2M Shares at $2.40 in Lieu of Milestone PaymentSeptember 7, 2016 9:17 AM Aurigene to Invest in Curis at Premium Through Waiver of Certain Milestone Payments Under Collaboration AgreementSeptember 7, 2016 6:55 AM